Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11901
PUT
Inovio Pharmaceuticals
INO
$120M
| $108K | ﹤0.01% |
61,900
+17,000
| +38% | +$28K |
2019 Q4
25 quarters
|
|
|
MCR
11902
DELISTED
MFS Charter Income Trust
MCR
| $108K | ﹤0.01% |
+17,773
| New | +$110K |
2026 Q1
0 quarters
|
|
11903
Scienjoy Holding
SJ
$35.1M
| $108K | ﹤0.01% |
85,400
+62,307
| +270% | +$74.8K |
2025 Q2
3 quarters
|
|
11904
PUT
Stagwell
STGW
$2.04B
| $108K | ﹤0.01% |
+17,100
| New | +$95.6K |
2026 Q1
0 quarters
|
|
|
PLMK
11905
Plum Acquisition Corp IV
PLMK
$114M
| $107K | ﹤0.01% |
+10,175
| New | +$107K |
2026 Q1
0 quarters
|
|
|
NTRBW
11906
DELISTED
Nutriband Inc Warrant
NTRBW
| $107K | ﹤0.01% |
95,709
-23,678
| -20% | -$36.2K |
2023 Q2
11 quarters
|
|
11907
InspireMD
NSPR
$29.2M
| $107K | ﹤0.01% |
65,750
-127,960
| -66% | -$218K |
2025 Q2
3 quarters
|
|
11908
CALL
Nano X Imaging
NNOX
$50M
| $107K | ﹤0.01% |
47,200
-79,800
| -63% | -$210K |
2020 Q3
22 quarters
|
|
|
MEVOU
11909
M Evo Global Acquisition Corp II Units
MEVOU
| $107K | ﹤0.01% |
+10,656
| New | +$107K |
2026 Q1
0 quarters
|
|
11910
PUT
Ambev
ABEV
$46.1B
| $107K | ﹤0.01% |
36,600
-2,800
| -7% | -$8K |
2025 Q3
2 quarters
|
|
11911
PUT
Star Holdings Shares of Beneficial Interest
STHO
$102M
| $107K | ﹤0.01% |
14,100
-1,600
| -10% | -$13.2K |
2025 Q3
2 quarters
|
|
11912
CALL
PharmaCyte Biotech
PMCB
$4.3M
| $107K | ﹤0.01% |
160,200
-25,900
| -14% | -$19.8K |
2025 Q3
2 quarters
|
|
11913
Hennessy Advisors
HNNA
$81.5M
| $107K | ﹤0.01% |
10,932
-5,959
| -35% | -$59.3K |
2025 Q3
2 quarters
|
|
11914
Zura Bio
ZURA
$394M
| $106K | ﹤0.01% |
17,898
-291,259
| -94% | -$1.76M |
2025 Q3
2 quarters
|
|
11915
CALL
Oportun Financial
OPRT
$384M
| $106K | ﹤0.01% |
+23,100
| New | +$118K |
2026 Q1
0 quarters
|
|
|
URG
11916
Ur-Energy
URG
$418M
| $106K | ﹤0.01% |
71,469
-2,060,443
| -97% | -$3.36M |
2025 Q2
3 quarters
|
|
|
ADBG
11917
PUT
Leverage Shares 2X Long ADBE Daily ETF
ADBG
$29.4M
| $106K | ﹤0.01% |
23,200
+9,000
| +63% | +$56.4K |
2025 Q4
1 quarter
|
|
|
ZKPU
11918
Lafayette Digital Acquisition Corp I Unit
ZKPU
| $106K | ﹤0.01% |
+10,722
| New | +$107K |
2026 Q1
0 quarters
|
|
|
CFND
11919
C1 Fund Inc
CFND
$20M
| $106K | ﹤0.01% |
27,549
+6,626
| +32% | +$28.5K |
2025 Q4
1 quarter
|
|
|
ARTC
11920
Art Technology Acquisition Corp
ARTC
| $106K | ﹤0.01% |
+10,815
| New | +$106K |
2026 Q1
0 quarters
|
|
|
LEGO.U
11921
Legato Merger Corp IV Units
LEGO.U
| $106K | ﹤0.01% |
+10,617
| New | +$106K |
2026 Q1
0 quarters
|
|
11922
CALL
Caesarstone
CSTE
$99.2M
| $106K | ﹤0.01% |
99,000
-2,400
| -2% | -$3.95K |
2025 Q4
1 quarter
|
|
|
TSI
11923
TCW Strategic Income Fund
TSI
$273M
| $106K | ﹤0.01% |
+23,585
| New | +$112K |
2026 Q1
0 quarters
|
|
|
CANF
11924
Can-Fite BioPharma American Depositary Shares
CANF
$4.67M
| $106K | ﹤0.01% |
+34,150
| New | +$141K |
2026 Q1
0 quarters
|
|
|
CHECU
11925
Chenghe Acquisition III Co Units
CHECU
| $106K | ﹤0.01% |
10,466
-150
| -1% | -$1.52K |
2025 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.